Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Protalix BioTherapeutics, Inc. | VP, Research & Development | Common Stock | 35.1K | $49.5K | $1.41 | Aug 15, 2023 | By Trust |
Protalix BioTherapeutics, Inc. | VP, Research & Development | Stock Options (Right to Buy) | 35.1K | Aug 15, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PLX | Protalix BioTherapeutics, Inc. | Aug 15, 2023 | 2 | $0 | 4 | Aug 17, 2023 | VP, Research & Development |
PLX | Protalix BioTherapeutics, Inc. | Sep 7, 2022 | 1 | $0 | 4 | Sep 9, 2022 | VP, Research & Development |